|Alex Denner, once Carl Icahn’s right hand investment manager in several successful activist investor drug company turnarounds, is ready to launch his own health care-focused hedge fund, Sarissa Capital Management LP. According to Bloomberg, Denner’s Sarissa Capital hedge fund will launch this summer with seed capital from Meritage Group LP. |
Sarissa Capital Management will take a long-bias approach in building a relatively small portfolio of companies in which it will apply its activist strategy. According to insiders, as much as 50 percent of the portfolio will be comprised of a core group of no more than five positions. Alex Denner is known for being an instrumental participant in Carl Icahn’s high profile success in turning around cancer-drug maker ImClone from 2002 and 2008.
|Hedge Fund Lists|